New York-based fund emerges as Rubicon investor with 7.5% stake

New York-based fund emerges as Rubicon investor with 7.5% stake
By Paul McBeth July 10 (BusinessDesk) - Sophrosyne Capital, a New York-based fund manager, has emerged with a 7.5 percent in Rubicon after doubling the size of its investment in the New Zealand forestry biotech firm’s recent rights issue. The privately-held fund manager bought 700,000 shares, or 3.4 percent, for almost $260,000 in March, and subsequently subscribed for an extra 18.7 million shares for some US$3.3 million in this month's rights issue, according to a substantial shareholder notice. Rubicon raised $21 million in a fully-subscri...